Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)
Clinical trial NCT02583256 · COMPLETED
Trial details
- NCT number
- NCT02583256
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-29
- Primary completion
- 2016-11-15
- Enrollment
- 1601
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.